TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.

Daisuke Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.